Fingerprint
Dive into the research topics of 'Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically